✦ LIBER ✦
A pilot phase 2 study of oregovomab murine monoclonal antibody to CA125 as an immunotherapeutic agent for recurrent ovarian cancer
✍ Scribed by T.G. EHLEN; P.J. HOSKINS; D. MILLER; T.L. WHITESIDE; C.F. NICODEMUS; B.C. SCHULTES; K.D. SWENERTON
- Book ID
- 109085416
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 198 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1048-891X
No coin nor oath required. For personal study only.